Concepedia
Statistics
Publications
16
Citations
765
H-Index
14
Active since
2000
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United Kingdom)
Karolinska Institutet
Medivir (Sweden)
RISE Research Institutes of Sweden
Anna-Karin Sohlenius-Sternbeck is an author at AstraZeneca (Sweden) specializing in medicine, metabolomics, and health sciences.
Top concepts
MedicineMetabolomicsHealthMetabolismPhysiologyLiver PhysiologyBiochemistryPharmacologyPharmacokineticsToxicology
Publications per year
2000–2022
Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements
Anna-Karin Sohlenius-Sternbeck · Toxicology in Vitro · 2006 · 250 citations
Pathology, Hepatocellularity Number, Bioanalysis +17
Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds
Anna-Karin Sohlenius-Sternbeck, Lovisa Afzelius, Peteris Prūsis et al. · Xenobiotica · 2010 · 127 citations
Human Prediction, Drug Compounds, Microsome Cl +16
Practical use of the regression offset approach for the prediction of<i>in vivo</i>intrinsic clearance from hepatocytes
Anna-Karin Sohlenius-Sternbeck, Chris Jones, Douglas Ferguson et al. · Xenobiotica · 2012 · 92 citations
Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work
Anna-Karin Sohlenius-Sternbeck, Ylva Terelius · Drug Metabolism and Disposition · 2021 · 63 citations · Full text
The Impact of Solute Carrier (SLC) Drug Uptake Transporter Loss in Human and Rat Cryopreserved Hepatocytes on Clearance Predictions
Patrik Lundquist, Johan Lööf, Anna-Karin Sohlenius-Sternbeck et al. · Drug Metabolism and Disposition · 2014 · 39 citations
1–5 of 16